- Home>
- Specialties>
- Cardiology>
- Atrial Fibrillation
Search for Atrial Fibrillation in Cardiology
Physician-authored summaries on the latest research on atrial fibrillation, editorials on atrial fibrillation, and perspectives on atrial fibrillation - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 311 results - Relevance
- Date
You searched for: atrial fibrillation in Cardiology
-
Among Older Patients with AF, Stroke Risk Is Higher in Women Than in Men
- May 16, 2012
- JoAnne M. Foody, MD
- Cardiology
In a population-based cohort, the increase was independent of comorbidities, baseline risk score, or warfarin use.- Reviewing:
- Avgil Tsadok M et al., JAMA 2012 May 9; 307:1952.
-
Dabigatran Associated with Increased Bleeding During Atrial Fibrillation Ablation
- February 29, 2012
- Mark S. Link, MD
- Cardiology
Until the effects of dabigatran use during ablation are clearer, it should be withheld for at least 24 hours before the procedure.- Reviewing:
- Lakkireddy D et al., J Am Coll Cardiol 2012 Feb 1;: Knight BP., J Am Coll Cardiol 2012 Feb 1;:
-
Even Subclinical AF Is Associated with Stroke
- January 18, 2012
- Mark S. Link, MD
- Cardiology
In patients with pacemakers, asymptomatic AF is common and warrants increased vigilance.- Reviewing:
- Healey JS et al., N Engl J Med 2012 Jan 12; 366:120. Lamas G., N Engl J Med 2012 Jan 12; 366:178.
-
Even with Anticoagulation Therapy, Higher CHADS2 Scores Predict Worse Outcomes
- December 21, 2011
- Joel M. Gore, MD
- Cardiology
In a RE-LY substudy, the correlation was present and similar in all treatment arms.- Reviewing:
- Oldgren J et al., Ann Intern Med 2011 Nov 15; 155:660. Beyth RJ and Landefeld CS., Ann Intern Med 2011 Nov 15; 155:714.
-
Antiplatelet Therapy for Atrial Fibrillation: One Drug or Two?
- December 7, 2011
- Joel M. Gore, MD
- Cardiology
In an ACTIVE substudy, the net clinical benefit of adding clopidogrel to aspirin in patients who were not candidates for warfarin was small and statistically nonsignificant.- Reviewing:
- Connolly SJ et al., Ann Intern Med 2011 Nov 1; 155:579.
-
When Is Dabigatran More Cost-Effective Than Warfarin?
- December 7, 2011
- Mark S. Link, MD
- Cardiology
For patients with nonvalvular atrial fibrillation who are not well-controlled on warfarin, the 150-mg dose of dabigatran can be a cost-effective choice for stroke prevention.- Reviewing:
- Pink J et al., BMJ 2011 Oct 31; 343:d6333. Gage BF., BMJ 2011 Oct 31; 343:d6980.
-
Dronedarone: A Cautionary Tale from PALLAS Free
- November 14, 2011
- Mark S. Link, MD
- Cardiology
Dronedarone increased the risk for cardiovascular events in high-risk patients with permanent atrial fibrillation of at least 6 months' duration.
CME Exam- Reviewing:
- Connolly SJ et al. for the PALLAS Investigators., N Engl J Med 2011 Nov 14;: Nattel S., N Engl J Med 2011 Nov 14;:
-
Can Atrial Fibrillation Cause MR?
- October 12, 2011
- Howard C. Herrmann, MD
- Cardiology
In patients with AF and normal-leaflet-motion MR, those who were in sinus rhythm after AF ablation had less MR than those with recurrent AF.
CME Exam- Reviewing:
- Gertz ZM et al., J Am Coll Cardiol 2011 Sep 27; 58:1474. Hoit BD., J Am Coll Cardiol 2011 Sep 27; 58:1482.
-
ARISTOTLE: Another Competitor Beats Warfarin Free
- August 29, 2011
- Mark S. Link, MD
- Cardiology
Apixaban, a factor Xa inhibitor, outperforms warfarin at stroke and systolic embolism prevention in AF patients.
CME Exam- Reviewing:
- Granger CB et al., N Engl J Med 2011 Aug 28;: Mega JL., N Engl J Med 2011 Aug 28;:
-
Rivaroxaban Enters the Arsenal for Stroke Prevention in AFib Free
- August 10, 2011
- Harlan M. Krumholz, MD, SM
- Cardiology
Another anticoagulant proves noninferior to warfarin.
CME Exam- Reviewing:
- Patel MR et al. for the ROCKET AF Investigators., N Engl J Med 2011 Aug 10;: del Zoppo GJ and Eliasziw M., N Engl J Med 2011 Aug 10;:
-
Angiotensin-Receptor Blockers in Patients with Atrial Fibrillation
- March 16, 2011
- Harlan M. Krumholz, MD, SM
- Cardiology
Irbesartan fails to reduce adverse event rates in ACTIVE I participants.- Reviewing:
- The ACTIVE I Investigators., N Engl J Med 2011 Mar 10; 364:928.
-
Another Contender in the Race to Unseat Warfarin Free
- February 10, 2011
- Mark S. Link, MD
- Cardiology
Compared with aspirin, apixaban reduced the risk for embolic events in patients with atrial fibrillation.
CME Exam- Reviewing:
- Connolly SJ et al. for the AVERROES Steering Committee and Investigators., N Engl J Med 2011 Feb 10;:
-
ACC/AHA Focused Update: Management of Atrial Fibrillation Free
- January 12, 2011
- Mark S. Link, MD
- Cardiology
Recent studies of rate-control targets, anticoagulation strategies, dronedarone, and catheter ablation drive changes to the 2006 guidelines.
CME Exam- Reviewing:
- Wann LS et al., Circulation 2011 Jan 4/11; 123:104.
-
Omega-3 Fatty Acids and Atrial Fibrillation Free
- November 15, 2010
- Mark S. Link, MD
- Cardiology
In a short-term, randomized, controlled trial, a prescription-strength fish oil supplement failed to prevent AF recurrence.- Reviewing:
- Kowey PR et al., JAMA 2010 Nov 15;:
-
A Head-to-Head Comparison of Two Drugs for Atrial Fibrillation
- September 15, 2010
- Mark S. Link, MD
- Cardiology
In a short-term randomized study, dronedarone was less toxic than amiodarone, but also less effective.- Reviewing:
- Le Heuzey J-Y et al., J Cardiovasc Electrophysiol 2010 Jun 1; 21:597.
-
More Good News About Dabigatran
- August 30, 2010
- Mark S. Link, MD
- Cardiology
Dabigatran's advantages over warfarin are increased at centers with poor control of international normalized ratio in warfarin therapy.- Reviewing:
- Wallentin L et al., Lancet 2010 Aug 29;:
-
Awareness and Treatment of Atrial Fibrillation
- April 14, 2010
- Joel M. Gore, MD
- Cardiology
Blacks with AF are less likely than whites both to know about their condition and to receive warfarin for it.- Reviewing:
- Meschia JF et al., Stroke 2010 Apr 1; 41:581.
-
Rate Control for Atrial Fibrillation: Can We Relax? Free
- March 15, 2010
- Mark S. Link, MD
- Cardiology
In a randomized trial, patients whose heart rates were strictly controlled fared no better than those treated more leniently — at least in the short term.
CME Exam- Reviewing:
- Van Gelder IC et al., N Engl J Med 2010 Mar 15;: Dorian P., N Engl J Med 2010 Mar 15;:
-
Catheter Ablation Bests Antiarrhythmic Drugs for Drug-Refractory Paroxysmal AFib
- February 3, 2010
- Mark S. Link, MD
- Cardiology
Radiofrequency pulmonary-vein ablation outperformed drug therapy in limiting AF recurrence and improving quality of life.
CME Exam- Reviewing:
- Wilber DJ et al. for the ThermoCool AF Trial Investigators., JAMA 2010 Jan 27; 303:333.
-
Does the Choice of Antihypertensive Agent Affect Risk for AFib?
- February 3, 2010
- Joel M. Gore, MD
- Cardiology
In a case-control study, ACE inhibitors, ARBs, and beta-blockers were associated with a reduction in incident AF compared with calcium-channel blockers.- Reviewing:
- Schaer BA et al., Ann Intern Med 2010 Jan 19; 152:78.
Sort by:
Items 1 to 20 of 311 results - Relevance
- Date
